168 related articles for article (PubMed ID: 8804422)
1. IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.
Rolling C; Treton D; Pellegrini S; Galanaud P; Richard Y
FEBS Lett; 1996 Sep; 393(1):53-6. PubMed ID: 8804422
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
Malabarba MG; Rui H; Deutsch HH; Chung J; Kalthoff FS; Farrar WL; Kirken RA
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
[TBL] [Abstract][Full Text] [Related]
3. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
Umeshita-Suyama R; Sugimoto R; Akaiwa M; Arima K; Yu B; Wada M; Kuwano M; Nakajima K; Hamasaki N; Izuhara K
Int Immunol; 2000 Nov; 12(11):1499-509. PubMed ID: 11058569
[TBL] [Abstract][Full Text] [Related]
4. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
5. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.
Roy B; Bhattacharjee A; Xu B; Ford D; Maizel AL; Cathcart MK
J Leukoc Biol; 2002 Sep; 72(3):580-9. PubMed ID: 12223527
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
7. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.
Murata T; Noguchi PD; Puri RK
J Biol Chem; 1995 Dec; 270(51):30829-36. PubMed ID: 8530527
[TBL] [Abstract][Full Text] [Related]
8. Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway.
Murata T; Husain SR; Mohri H; Puri RK
Int Immunol; 1998 Aug; 10(8):1103-10. PubMed ID: 9723696
[TBL] [Abstract][Full Text] [Related]
9. Binding of IL-4 to the IL-13Ralpha(1)/IL-4Ralpha receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation.
Wery-Zennaro S; Letourneur M; David M; Bertoglio J; Pierre J
FEBS Lett; 1999 Dec; 464(1-2):91-6. PubMed ID: 10611490
[TBL] [Abstract][Full Text] [Related]
10. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling.
Murata T; Noguchi PD; Puri RK
J Immunol; 1996 Apr; 156(8):2972-8. PubMed ID: 8609418
[TBL] [Abstract][Full Text] [Related]
11. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.
Demoulin JB; Uyttenhove C; Van Roost E; DeLestré B; Donckers D; Van Snick J; Renauld JC
Mol Cell Biol; 1996 Sep; 16(9):4710-6. PubMed ID: 8756628
[TBL] [Abstract][Full Text] [Related]
12. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells.
Murata T; Puri RK
Cell Immunol; 1997 Jan; 175(1):33-40. PubMed ID: 9015186
[TBL] [Abstract][Full Text] [Related]
13. Constitutive association of JAK1 and STAT5 in pro-B cells is dissolved by interleukin-4-induced tyrosine phosphorylation of both proteins.
Erhardt I; Lischke A; Sebald W; Friedrich K
FEBS Lett; 1998 Nov; 439(1-2):71-4. PubMed ID: 9849880
[TBL] [Abstract][Full Text] [Related]
14. JAK3 associates with the human interleukin 4 receptor and is tyrosine phosphorylated following receptor triggering.
Rolling C; Treton D; Beckmann P; Galanaud P; Richard Y
Oncogene; 1995 May; 10(9):1757-61. PubMed ID: 7538655
[TBL] [Abstract][Full Text] [Related]
15. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha.
Malabarba MG; Kirken RA; Rui H; Koettnitz K; Kawamura M; O'Shea JJ; Kalthoff FS; Farrar WL
J Biol Chem; 1995 Apr; 270(16):9630-7. PubMed ID: 7721895
[TBL] [Abstract][Full Text] [Related]
16. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain.
Lischke A; Moriggl R; Brändlein S; Berchtold S; Kammer W; Sebald W; Groner B; Liu X; Hennighausen L; Friedrich K
J Biol Chem; 1998 Nov; 273(47):31222-9. PubMed ID: 9813029
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of IL-4 and IL-13 on CD44 expression in the Burkitt's lymphoma B cell line BL30/B95-8 and in Epstein-Barr virus (EBV) transformed human B cells: loss of IL-13 receptors on Burkitt's lymphoma B cells.
Gee K; Kozlowski M; Kryworuchko M; Diaz-Mitoma F; Kumar A
Cell Immunol; 2001 Aug; 211(2):131-42. PubMed ID: 11591117
[TBL] [Abstract][Full Text] [Related]
19. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1.
Haque SJ; Wu Q; Kammer W; Friedrich K; Smith JM; Kerr IM; Stark GR; Williams BR
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8563-8. PubMed ID: 9238016
[TBL] [Abstract][Full Text] [Related]
20. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line.
Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Nakamura M; Van Snick J; Sugamura K
Eur J Immunol; 1996 Jun; 26(6):1322-7. PubMed ID: 8647212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]